G

Grand Pharmaceutical Group Ltd
HKEX:512

Watchlist Manager
Grand Pharmaceutical Group Ltd
HKEX:512
Watchlist
Price: 7.87 HKD 0.25% Market Closed
Market Cap: 27.9B HKD

Profitability Summary

Grand Pharmaceutical Group Ltd's profitability score is 53/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

53/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

53/100
Profitability
Score
53/100
Profitability
Score

Margins

Earnings Waterfall
Grand Pharmaceutical Group Ltd

Margins Comparison
Grand Pharmaceutical Group Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
HK
Grand Pharmaceutical Group Ltd
HKEX:512
27.6B HKD
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
524.6B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
275.8B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.2B GBP
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
276.4B USD
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
219.6B CHF
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
147.2B USD
Loading...
Loading...
Loading...
No Stocks Found

Return on Capital

Return on Capital Comparison
Grand Pharmaceutical Group Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
HK
Grand Pharmaceutical Group Ltd
HKEX:512
27.6B HKD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
524.6B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
275.8B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.2B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
276.4B USD
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
219.6B CHF
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
147.2B USD
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Free Cash Flow

Free Cash Flow Analysis
Grand Pharmaceutical Group Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate